hrp0082p3-d2-1000 | Thyroid (1) | ESPE2014

Changes of Laboratory Findings Before and After Thyroid Hormone Replacement in a Naïve 19.24 Year-Old Female Case of Ectopic Thyroid

Oh Phil Soo , Choi Joong Wan

Background: Hypothyroidsim is known to be associated with liver function, cholesterol and some hormone levels including GH. But, there are fewer reports about the gonadotropin levels in thyroid dysfunction.Objectives and hypotheses: We report here some interesting laboratory findings in a 19.24-year-old severe short stature female case of ectopic thyroid.Methods: Laboratory investigations including the combined anterior pituitary f...

hrp0084p2-295 | Diabetes | ESPE2015

Sirolimus Therapy in Infants with Congenital Hyperinsulinism after Near Total Pancreatectomy

Choi keun Hee , Chung Hye Rim

Background: Congenital hyperinsulinism is the most common cause of persistent hypoglycaemia in neonates and children. It is important to minimize recurrence of episodes of hypoglycaemia. In some cases, Hypoglycemia was not controlled even after near total pancreatectomy.Objective and hypotheses: To study the glycemic response of sirolimus in patients with hyperinsulinemic hypoglycaemia that was not responsive to octreotide and calcium channel blocker aft...

hrp0097p1-418 | Bone, Growth Plate and Mineral Metabolism | ESPE2023

Comparison of efficacy and safety of oral cholecalciferol administration at 4-week intervals and daily administration to correct vitamin D deficiency in adolescents

Choi Jinjoo , Choe Yunsoo , Yang Seung

Objectives: Vitamin D deficiency is prevalent in pediatric population. Since low compliance may inhibit appropriate vitamin D supplementation in daily dosing regimen, intermittent high dose administration may be considered. We aimed to evaluate the efficacy and safety of monthly administration of oral cholecalciferol compared with daily dosing regimen in adolescents with vitamin D deficiency.Methods: This retrospective s...

hrp0095p1-253 | Diabetes and Insulin | ESPE2022

Incidence and risk factors for paediatric diabetic retinopathy: case control for a tertiary hospital in Leeds, United Kingdom

Hester Holly , Adams Elizabeth , Kelleher Aoife , Yong James , Campbell Fiona

Introduction: Diabetic retinopathy is a leading microvascular complication and preventable cause of vision loss. NHS diabetes eye screening program (DESP) assesses for early signs, with population prevalence between 3.5% and 24.2%. Understanding the factors involved is important to reduce morbidity.Aims and objectives: Establish clinical characteristics and modifiable risk factors for patients with retinopathy identified...

hrp0089p2-p306 | Pituitary, Neuroendocrinology and Puberty P2 | ESPE2018

Longitudinal Follow-up to Near Final Height of Auxological Changes in Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analog and Grouped by Pretreatment BMI level

Park Jongho , Kim Yong-Dae , Han Heon-Seok

Purpose: Reported changes in BMI in central precocious puberty (CPP) during and after gonadotropin-releasing hormone analog (GnRHa) treatment are inconsistent. We, therefore, investigated auxological parameters in GnRHa-treated girls with idiopathic CPP (ICPP) until attainment of near final height (NFH).Methods: From the medical records of 59 ICPP girls who attained NFH after GnRHa therapy, auxological changes were compared between overweight (BMI &#8805...

hrp0082p2-d3-355 | Diabetes (2) | ESPE2014

Glycaemic Control and Microvascular Complications in Adolescents and Young Adults with Type 1 Diabetes: Outcome Following Transfer of Care to Adult Services

Uday Suma , Campbell Fiona , Yong James , Ajjan Ramzi

Introduction: Transition of young adults with diabetes has received much attention in recent years. Despite concerns regarding deterioration in glycaemic control and lack of engagement in services following transfer of care from paediatric to adult services, very few studies have looked at the effect of transfer on glycaemic control and clinic attendance as the primary outcome.Objectives: To establish the glycaemic control and rate of microvascular compl...

hrp0084p2-284 | Diabetes | ESPE2015

In-Patient Care for Children with Type 1 Diabetes – A Regional Audit in the Yorkshire and Humber Region in the North of England

Uday Suma , Amin Nadia , Campbell Fiona , Yong James

Introduction: An important part of diabetes management is maintaining high standards of in-patient care. A previous audit in the South of England demonstrated difficulties consistently achieving standards identified as good practice.Objectives: To identify variations in in-patient care provided to children with type 1 diabetes across the Yorkshire and Humber region.Methods: The audit was conducted against in-patient care standards ...

hrp0084p2-291 | Diabetes | ESPE2015

Metformin Utilisation Patterns in Paediatric Population Aged 10–19 Years in the US: 2009–2013

Wang Tongtong , McNeill Ann Marie , Chen Yong , Shankar Ravi

Background: Metformin is the only oral antihyperglycaemic agent (AHA) approved for use in youths with type 2 diabetes mellitus (T2DM). It may also be used to treat other conditions such as hyperinsulinaemia, pre-diabetes, and polycystic ovarian syndrome (PCOS). Therefore, an assessment of the prevalence of T2DM in the paediatric population based on the utilisations for metformin may overestimate the burden of the disease. However, metformin utilisation patterns in youths remai...

hrp0084p2-352 | Fat | ESPE2015

Metformin Prescriptions as a Proxy for Paediatric Type 2 Diabetes Burden

McNeill Ann Marie , Wang Tongtong , Chen Yong , Shankar Ravi

Background: Since metformin (MET), approved for treatment of type 2 diabetes (T2D), is the most commonly used oral anti-hyperglycaemic agent in youths MET prescriptions (Rx) could be used as a proxy for T2D burden in these populations. However, the extent of off-label use of MET in paediatrics is not well studied.Objective and hypotheses: Estimate the annual prevalence of ≥1 MET Rx among youths and calculate proportions with concomitant diagnoses o...

hrp0084p3-1076 | Hypo | ESPE2015

Hyperinsulinism Secondary to Congenital Portosystemic Shunt in a Neonate

Hong Yong Hee , Lee Dong Hoon , Kim Sung Shin

Background: Hyperinsulinism is a common cause of persistent hypoglycaemia in infant. Insulin secretion from pancreatic β-cells is unregulated and inappropriate for the level of blood glucose, causing glucose into the insulin-sensitive tissues, such as the muscle, liver and adipose tissue, leading to hyperinsulinaemic hypoglycaemia. But congenital portosystemic shunt, a rare vascular malformation, can cause hyperinsulinaemic hypoglycaemia rarely because glucose from portal...